CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | organoselenium compound |
|
Accession: | CHEBI:25712
|
browse the term
|
Definition: | An organoselenium compound is a compound containing at least one carbon-selenium bond. |
Synonyms: | related_synonym: | organoselenium compounds |
| alt_id: | MESH:D016566 |
| xref_mesh: | MESH:D016566 |
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of ABCC2 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP ISO |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] [Organoselenium Compounds binds to Copper] which results in decreased expression of AKT1 protein |
CTD |
PMID:18538761 PMID:25167922 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of BAX protein] |
CTD |
PMID:25301743 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein] |
CTD |
PMID:25301743 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
increases cleavage |
ISO |
Organoselenium Compounds results in increased cleavage of CASP3 protein |
CTD |
PMID:24905917 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of CDKN1A protein] |
CTD |
PMID:25301743 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Organoselenium Compounds binds to and results in decreased activity of CYP1A1 protein |
CTD |
PMID:21732699 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
Organoselenium Compounds binds to and results in decreased activity of CYP1A2 protein |
CTD |
PMID:21732699 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions |
ISO |
Organoselenium Compounds binds to and results in decreased activity of CYP1B1 protein |
CTD |
PMID:21732699 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
Organoselenium Compounds binds to and results in decreased activity of CYP2A13 protein |
CTD |
PMID:21732699 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Dnaja1 |
DnaJ heat shock protein family (Hsp40) member A1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJA1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
|
|
G |
Dnaja4 |
DnaJ heat shock protein family (Hsp40) member A4 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJA4 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 8:55,085,246...55,102,715
Ensembl chr 8:55,085,464...55,101,207
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb4 |
DnaJ heat shock protein family (Hsp40) member B4 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 2:241,129,346...241,159,272
Ensembl chr 2:241,130,340...241,159,089
|
|
G |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB9 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases activity |
ISO |
Organoselenium Compounds results in increased activity of EPHX1 protein |
CTD |
PMID:17163488 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Streptozocin results in increased expression of FN1 protein] |
CTD |
PMID:25301743 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of FOS mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosl1 |
FOS like 1, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of FOSL1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of GCLM mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
ISO |
[Organoselenium Compounds co-treated with Lipopolysaccharides] results in increased expression of GPX1 protein Organoselenium Compounds results in increased expression of GPX1 protein |
CTD |
PMID:20883674 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Herpud1 |
homocysteine inducible ER protein with ubiquitin like domain 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HERPUD1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HMOX1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in decreased expression of HSP90AA1 protein; [Organoselenium Compounds binds to Copper] which results in increased expression of HSP90AA1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1B mRNA |
CTD |
PMID:25167922 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspa1l |
heat shock protein family A (Hsp70) member 1 like |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA1L mRNA |
CTD |
PMID:25167922 |
|
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
|
|
G |
Hspa6l-ps1 |
heat shock protein family A (Hsp70) member 6 like, pseudogene 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPA6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr13:83,273,176...83,274,317
|
|
G |
Hspb8 |
heat shock protein family B (small) member 8 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPB8 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
|
|
G |
Hsph1 |
heat shock protein family H (Hsp110) member 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of HSPH1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
Organoselenium Compounds inhibits the reaction [Freund's Adjuvant results in increased expression of IFNG mRNA] |
CTD |
PMID:31400342 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:18538761 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of JUN mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of JUNB mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Maff |
MAF bZIP transcription factor F |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
|
|
G |
Mafg |
MAF bZIP transcription factor G |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:105,903,307...105,911,808
Ensembl chr10:105,903,237...105,912,026
|
|
G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:95,373,304...95,490,406
Ensembl chr10:95,373,204...95,488,293
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation increases activity |
EXP |
Organoselenium Compounds analog results in increased phosphorylation of MAPK1 protein Organoselenium Compounds results in increased activity of MAPK1 protein |
CTD |
PMID:21960664 PMID:22001386 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk15 |
mitogen-activated protein kinase 15 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MAPK15 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 7:107,694,907...107,714,640
Ensembl chr 7:107,694,964...107,714,645
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases activity increases phosphorylation |
EXP |
Organoselenium Compounds results in increased activity of MAPK3 protein Organoselenium Compounds analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:21960664 PMID:22001386 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP10 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp25 |
matrix metallopeptidase 25 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MMP25 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:12,661,297...12,676,119
Ensembl chr10:12,661,208...12,675,871
|
|
G |
Mt1-ps3 |
metallothionein 1, pseudogene 3 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT1E mRNA |
CTD |
PMID:25167922 |
|
NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of MT2A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of NOS2 protein] Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:18538761 PMID:20883674 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Organoselenium Compounds results in increased cleavage of PARP1 protein |
CTD |
PMID:24905917 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pgf |
placental growth factor |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of PGF mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
|
|
G |
Pik3r5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of PIK3R5 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in decreased expression of PIM1 protein; [Organoselenium Compounds binds to Copper] which results in increased expression of PIM1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of PPP1R15A mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases activity |
ISO EXP |
Organoselenium Compounds inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 mRNA]; Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of PTGS2 protein] Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA] Organoselenium Compounds results in decreased activity of PTGS2 protein |
CTD |
PMID:18538761 PMID:20883674 PMID:31400342 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] |
CTD |
PMID:18538761 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of SGK1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
Organoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of SIRT1 protein] |
CTD |
PMID:25301743 |
|
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a3 |
solute carrier family 2 member 3 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of SLC2A3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of SQSTM1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO EXP |
Organoselenium Compounds results in decreased susceptibility to [Lipopolysaccharides results in increased expression of TNF mRNA] Organoselenium Compounds results in decreased expression of TNF protein Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Organoselenium Compounds inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
CTD |
PMID:18538761 PMID:20883674 PMID:31400342 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of TRIB3 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of TXNRD1 mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in increased expression of VEGFA mRNA |
CTD |
PMID:25167922 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vegfc |
vascular endothelial growth factor C |
multiple interactions |
ISO |
[Organoselenium Compounds binds to Copper] which results in decreased expression of VEGFC mRNA |
CTD |
PMID:25167922 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
|
G |
Aak1 |
AP2 associated kinase 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:119,300,128...119,451,834
Ensembl chr 4:119,295,257...119,450,969
|
|
G |
Acbd3 |
acyl-CoA binding domain containing 3 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:92,455,813...92,484,556
Ensembl chr13:92,455,655...92,483,380
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of ACHE mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ankar |
ankyrin and armadillo repeat containing |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in increased expression of ANKAR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:48,141,534...48,215,400
Ensembl chr 9:48,141,391...48,215,616
|
|
G |
Arap1 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS1 mRNA] which results in increased expression of ARAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ARAP1-AS2 mRNA] which results in increased expression of ARAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:155,748,622...155,814,186
Ensembl chr 1:155,748,652...155,814,184
|
|
G |
Arhgap30 |
Rho GTPase activating protein 30 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ARHGAP30 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:83,822,290...83,843,634
Ensembl chr13:83,822,283...83,854,885
|
|
G |
Bex1 |
brain expressed X-linked 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of BEX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
|
|
G |
C2h4orf3 |
similar to human chromosome 4 open reading frame 3 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of C4ORF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:211,055,925...211,057,685
Ensembl chr 2:211,055,911...211,057,681
|
|
G |
C5ar1 |
complement C5a receptor 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of C5AR1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:76,948,622...76,959,826
|
|
G |
Catip |
ciliogenesis associated TTC17 interacting protein |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CATIP-AS1 mRNA] which results in increased expression of CATIP mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:75,945,960...75,953,618
Ensembl chr 9:75,945,961...75,953,607
|
|
G |
Ccdc183 |
coiled-coil domain containing 183 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CCDC183-AS1 mRNA] which results in increased expression of CCDC183 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:8,428,784...8,438,948
Ensembl chr 3:8,428,787...8,437,194
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of CDH2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Celf3 |
CUGBP, Elav-like family member 3 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:182,116,034...182,130,163
Ensembl chr 2:182,116,073...182,130,163
|
|
G |
Cimap1c |
ciliary microtubule associated protein 1C |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNM1P35 mRNA] which results in increased expression of CIMAP1C mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:57,248,746...57,281,084
Ensembl chr 8:57,248,746...57,281,004
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS1 mRNA] which results in decreased expression of COL4A2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of COL4A2-AS2 mRNA] which results in decreased expression of COL4A2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Coro1a |
coronin 1A |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of CORO1A-AS1 mRNA] which results in decreased expression of CORO1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Ddit4 |
DNA-damage-inducible transcript 4 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of DDIT4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
|
|
G |
Ddx59 |
DEAD-box helicase 59 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DDX59-AS1 mRNA] which results in increased expression of DDX59 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:47,876,258...47,901,214
Ensembl chr13:47,876,261...47,901,214
|
|
G |
Dlgap1 |
DLG associated protein 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of DLGAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
|
|
G |
Dnmt3l |
DNA methyltransferase 3 like |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of DNMT3L mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:10,614,933...10,629,337
Ensembl chr20:10,614,934...10,629,516
|
|
G |
Dock3 |
dedicator of cyto-kinesis 3 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
|
|
G |
Dynlt2b |
dynein light chain Tctex-type 2B |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in increased expression of DYNLT2B mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:68,359,138...68,367,573
Ensembl chr11:68,358,263...68,367,499
|
|
G |
E2f8 |
E2F transcription factor 8 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of CSRP3-AS1 mRNA] which results in increased expression of E2F8 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:144,929,195...145,052,723
Ensembl chr 3:144,984,640...145,052,721
|
|
G |
Fam83f |
family with sequence similarity 83, member F |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNRC6B-DT mRNA] which results in increased expression of FAM83F mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
|
|
G |
Fhad1 |
forkhead associated phosphopeptide binding domain 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FHAD1-AS1 mRNA] which results in increased expression of FHAD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:154,191,593...154,310,442
Ensembl chr 5:154,191,745...154,310,354
|
|
G |
Flnb |
filamin B |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FLNB-AS1 mRNA] which results in decreased expression of FLNB mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:16,961,999...17,095,059
Ensembl chr15:16,962,003...17,095,006
|
|
G |
Flnc |
filamin C |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FLNC-AS1 mRNA] which results in increased expression of FLNC mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
|
|
G |
Foxc2 |
forkhead box C2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr19:49,186,034...49,188,736
Ensembl chr19:49,185,662...49,188,737
|
|
G |
Foxl2 |
forkhead box L2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01391 mRNA] which results in increased expression of FOXL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:99,512,971...99,514,500
Ensembl chr 8:99,513,303...99,514,427
|
|
G |
Gcc2 |
GRIP and coiled-coil domain containing 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:26,247,394...26,293,613
Ensembl chr20:26,247,404...26,293,613
|
|
G |
Gk |
glycerol kinase |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of GK-AS1 mRNA] which results in increased expression of GK mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
|
|
G |
Gsn |
gelsolin |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of GSN-AS1 mRNA] which results in decreased expression of GSN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HIF1A-AS1 mRNA] which results in decreased expression of HIF1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HK2-DT mRNA] which results in decreased expression of HK2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMGN3-AS1 mRNA] which results in decreased expression of HMGN3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:84,022,493...84,059,329
Ensembl chr 8:84,022,495...84,062,976
|
|
G |
Hmmr |
hyaluronan-mediated motility receptor |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of HMMR-AS1 mRNA] which results in decreased expression of HMMR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
|
|
G |
Hoxa10 |
homeobox A10 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:81,331,591...81,340,919
|
|
G |
Hoxb4 |
homeo box B4 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of HOXB4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:81,284,552...81,287,134
Ensembl chr10:81,284,552...81,287,128
|
|
G |
Hoxb9 |
homeo box B9 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
|
|
G |
Hoxc13 |
homeobox C13 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXC13-AS mRNA] which results in increased expression of HOXC13 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:134,058,640...134,065,479
Ensembl chr 7:134,058,640...134,064,800
|
|
G |
Icoslg |
inducible T-cell co-stimulator ligand |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of DNMT3L-AS1 mRNA] which results in increased expression of ICOSLG mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:10,600,420...10,610,718
Ensembl chr20:10,600,420...10,610,703
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
|
|
G |
Inhba |
inhibin subunit beta A |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of INHBA mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Insig1 |
insulin induced gene 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of INSIG1-DT mRNA] which results in decreased expression of INSIG1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Iqsec3 |
IQ motif and Sec7 domain ArfGEF 3 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IQSEC3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:154,610,933...154,707,310
Ensembl chr 4:154,610,934...154,707,310
|
|
G |
Irgq |
immunity-related GTPase Q |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of IRGQ mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:80,123,925...80,131,881
Ensembl chr 1:80,123,925...80,131,881
|
|
G |
Itga3 |
integrin subunit alpha 3 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of ITGA3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Kcna7 |
potassium voltage-gated channel subfamily A member 7 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of KCNA7 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of KCNA7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:95,886,073...95,891,565
Ensembl chr 1:95,886,073...95,891,565
|
|
G |
Kcnc4 |
potassium voltage-gated channel subfamily C member 4 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of KCNC4 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:195,063,967...195,100,244
Ensembl chr 2:195,071,769...195,099,233
|
|
G |
Kiaa1614 |
KIAA1614 homolog |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of KIAA1614-AS1 mRNA] which results in increased expression of KIAA1614 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of KIAA1614 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr13:67,388,916...67,427,392
Ensembl chr13:67,389,044...67,421,272
|
|
G |
Krt7 |
keratin 7 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Lbx2 |
ladybird homeobox 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of LBX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:115,591,974...115,593,859
Ensembl chr 4:115,591,974...115,594,132
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LIF-AS1 mRNA] which results in increased expression of LIF mRNA |
CTD |
PMID:33656867 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Lmnb1 |
lamin B1 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LMNB1-DT mRNA] which results in decreased expression of LMNB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
|
|
G |
Mafa |
MAF bZIP transcription factor A |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MAFA-AS1 mRNA] which results in increased expression of MAFA mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
|
|
G |
Marveld1 |
MARVEL domain containing 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in decreased expression of MARVELD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:240,954,050...240,958,101
Ensembl chr 1:240,954,452...240,958,384
|
|
G |
Mef2a |
myocyte enhancer factor 2a |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:120,847,874...120,982,488
Ensembl chr 1:120,850,080...120,981,948
|
|
G |
Metrn |
meteorin, glial cell differentiation regulator |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of METRN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:14,816,684...14,818,702
Ensembl chr10:14,816,572...14,818,701
|
|
G |
Mex3b |
mex-3 RNA binding family member B |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of MEX3B mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of MEX3B mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:136,855,130...136,859,354
|
|
G |
Mid1ip1 |
MID1 interacting protein 1 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of MID1IP1-AS1 mRNA] which results in increased expression of MID1IP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:12,060,993...12,063,318
Ensembl chr X:12,060,883...12,065,774
|
|
G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of MMEL1-AS1 mRNA] which results in decreased expression of MMEL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:165,431,278...165,461,716
Ensembl chr 5:165,431,343...165,461,716
|
|
G |
Mmrn2 |
multimerin 2 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ADIRF-AS1 mRNA] which results in increased expression of MMRN2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:9,705,925...9,727,405
Ensembl chr16:9,705,892...9,727,405
|
|
G |
Mypn |
myopalladin |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:25,429,898...25,522,443
Ensembl chr20:25,436,843...25,522,443
|
|
G |
Ngfr |
nerve growth factor receptor |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NGFR-AS1 mRNA] which results in increased expression of NGFR mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Npr3 |
natriuretic peptide receptor 3 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of NPR3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of NPR3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nucb1 |
nucleobindin 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of NUCB1-AS1 mRNA] which results in decreased expression of NUCB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
|
|
G |
Nyap1 |
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of NYAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:18,956,192...18,967,624
Ensembl chr12:18,956,268...18,967,543
|
|
G |
Osgepl1 |
O-sialoglycoprotein endopeptidase-like 1 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:48,214,995...48,229,440
Ensembl chr 9:48,215,402...48,229,388
|
|
G |
Otog |
otogelin |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:96,746,336...96,815,416
Ensembl chr 1:96,746,336...96,815,415
|
|
G |
Pgpep1 |
pyroglutamyl-peptidase I |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:18,770,563...18,782,968
Ensembl chr16:18,771,021...18,783,478
|
|
G |
Pilrb2l8 |
paired immunoglobin like type 2 receptor beta 2 like 8 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of ZNF37A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr12:17,744,315...17,756,074
Ensembl chr12:17,752,830...17,755,922
|
|
G |
Piwil2 |
piwi-like RNA-mediated gene silencing 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of PIWIL2-DT mRNA] which results in increased expression of PIWIL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
|
|
G |
Pla2g4e |
phospholipase A2, group IVE |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PLA2G4E-AS1 mRNA] which results in increased expression of PLA2G4E mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:107,132,540...107,198,609
Ensembl chr 3:107,132,541...107,198,233
|
|
G |
Plcl2 |
phospholipase C-like 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:3,292,564...3,477,009
Ensembl chr 9:3,292,695...3,477,009
|
|
G |
Polh |
DNA polymerase eta |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of POLH-AS1 mRNA] which results in increased expression of POLH mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 9:14,778,355...14,813,210
Ensembl chr 9:14,777,888...14,812,723
|
|
G |
Popdc2 |
popeye domain containing 2 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of POPDC2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:62,351,843...62,398,688
Ensembl chr11:62,374,759...62,390,756
|
|
G |
Prickle2 |
prickle planar cell polarity protein 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS1 mRNA] which results in increased expression of PRICKLE2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of PRICKLE2-AS3 mRNA] which results in increased expression of PRICKLE2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:124,869,655...125,214,862
Ensembl chr 4:124,869,552...125,214,824
|
|
G |
Psmb11 |
proteasome subunit beta 11 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:28,084,736...28,085,655
|
|
G |
Riiad1 |
regulatory subunit of type II PKA R-subunit domain containing 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of RIIAD1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:182,099,924...182,110,544
Ensembl chr 2:182,101,795...182,110,319
|
|
G |
S100a2 |
S100 calcium binding protein A2 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of S100A2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:176,077,081...176,078,325
|
|
G |
Samd14 |
sterile alpha motif domain containing 14 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SAMD14 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:79,957,111...79,972,347
Ensembl chr10:79,957,758...79,972,341
|
|
G |
Sema3g |
semaphorin 3G |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in increased expression of SEMA3G mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:6,413,589...6,425,221
Ensembl chr16:6,413,589...6,425,221
|
|
G |
Sh3rf3 |
SH3 domain containing ring finger 3 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SH3RF3-AS1 mRNA] which results in decreased expression of SH3RF3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr20:26,765,278...27,099,261
Ensembl chr20:26,765,015...27,099,257
|
|
G |
Shf |
Src homology 2 domain containing F |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SHF mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:109,296,517...109,316,315
Ensembl chr 3:109,296,784...109,316,328
|
|
G |
Skap1 |
src kinase associated phosphoprotein 1 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SKAP1-AS1 mRNA] which results in increased expression of SKAP1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:81,425,472...81,732,651
Ensembl chr10:81,425,525...81,732,650
|
|
G |
Slc25a34 |
solute carrier family 25, member 34 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:153,932,081...153,936,854
|
|
G |
Smad5 |
SMAD family member 5 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SMAD5-AS1 mRNA] which results in increased expression of SMAD5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr17:7,862,332...7,891,678
Ensembl chr17:7,864,720...7,891,634
|
|
G |
Smtnl2 |
smoothelin-like 2 |
multiple interactions |
ISO |
[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:57,008,322...57,029,505
Ensembl chr10:57,008,327...57,029,505
|
|
G |
Srcin1 |
SRC kinase signaling inhibitor 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PICART1 mRNA] which results in increased expression of SRCIN1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:82,502,911...82,569,882
Ensembl chr10:82,504,393...82,571,040
|
|
G |
Sstr5 |
somatostatin receptor 5 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of SSTR5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:14,506,868...14,512,946
Ensembl chr10:14,506,868...14,512,946
|
|
G |
Stab1 |
stabilin 1 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
|
|
G |
Syp |
synaptophysin |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of SYP-AS1 mRNA] which results in increased expression of SYP mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tab3 |
TGF-beta activated kinase 1 (MAP3K7) binding protein 3 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS2 mRNA] which results in increased expression of TAB3 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr X:49,972,414...50,044,658
Ensembl chr X:49,972,330...50,042,056
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Tlx2 |
T-cell leukemia homeobox 2 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA] which results in increased expression of TLX2 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 4:115,573,736...115,576,097
Ensembl chr 4:115,573,799...115,575,642
|
|
G |
Tm4sf19 |
transmembrane 4 L six family member 19 |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA] which results in decreased expression of TM4SF19 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr11:68,372,945...68,386,192
Ensembl chr11:68,371,647...68,384,591
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mRNA] which results in increased expression of TNFRSF10A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53i11 |
tumor protein p53 inducible protein 11 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of TP53I11 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 3:79,144,824...79,160,056
Ensembl chr 3:79,144,895...79,160,050
|
|
G |
Trim8 |
tripartite motif-containing 8 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:245,369,632...245,384,513
Ensembl chr 1:245,369,632...245,384,513
|
|
G |
Ttc23l |
tetratricopeptide repeat domain 23-like |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TTC23L-AS1 mRNA] which results in increased expression of TTC23L mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 2:59,476,666...59,538,313
Ensembl chr 2:59,476,669...59,538,282
|
|
G |
Upk1a |
uroplakin 1A |
multiple interactions |
ISO |
[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of UPK1A-AS1 mRNA] which results in increased expression of UPK1A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
|
|
G |
Wnt9a |
Wnt family member 9A |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:44,094,140...44,121,134
Ensembl chr10:44,094,140...44,121,133
|
|
G |
Zbtb5 |
zinc finger and BTB domain containing 5 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of ZBTB5 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr 5:59,244,132...59,265,461
Ensembl chr 5:59,243,307...59,265,426
|
|
G |
Zfp385d |
zinc finger protein 385D |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in decreased expression of ZNF385D mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:5,040,182...5,849,975
Ensembl chr15:5,042,572...5,423,367
|
|
G |
Zfp503 |
zinc finger protein 503 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr15:2,313,060...2,316,848
Ensembl chr15:2,313,060...2,316,848
|
|
G |
Zfp672 |
zinc finger protein 672 |
multiple interactions |
ISO |
[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA |
CTD |
PMID:33656867 |
|
NCBI chr10:42,496,558...42,512,134
Ensembl chr10:42,495,476...42,504,852
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:16757516 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adam9 |
ADAM metallopeptidase domain 9 |
multiple interactions |
ISO |
ebselen inhibits the reaction [Hydrogen Peroxide results in increased expression of ADAM9 protein] |
CTD |
PMID:17018608 |
|
NCBI chr16:67,022,538...67,101,647
Ensembl chr16:67,022,655...67,100,917
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
ebselen inhibits the reaction [Aflatoxin B1 results in increased expression of AFP mRNA] |
CTD |
PMID:11133813 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions decreases activity |
EXP ISO |
Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein] ebselen inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein] |
CTD |
PMID:14630126 PMID:17624921 PMID:23933410 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity |
ISO |
ebselen results in decreased activity of ALOX5 protein |
CTD |
PMID:7590103 |
|
NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
ebselen inhibits the reaction [sodium arsenite results in increased expression of BAX protein] |
CTD |
PMID:30558456 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP |
ebselen inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:30558456 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO EXP |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein] ebselen results in increased activity of CASP3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased activity of CASP3 protein]; ebselen inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] |
CTD |
PMID:21300091 PMID:23649643 PMID:25068500 PMID:30558456 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO EXP |
ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein] ebselen inhibits the reaction [Cadmium Chloride results in increased activity of CASP9 protein] |
CTD |
PMID:18629305 PMID:23649643 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP |
ebselen results in increased activity of CAT protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cox4i1 |
cytochrome c oxidase subunit 4i1 |
increases expression |
ISO |
ebselen results in increased expression of COX4I1 protein |
CTD |
PMID:27385396 |
|
NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921
|
|
G |
Cs |
citrate synthase |
multiple interactions |
ISO EXP |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] ebselen inhibits the reaction [Cisplatin results in decreased activity of CS protein] |
CTD |
PMID:27385396 PMID:32860823 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
increases phosphorylation |
EXP |
ebselen results in increased phosphorylation of EIF2S1 protein |
CTD |
PMID:27282967 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Ephx2 |
epoxide hydrolase 2 |
multiple interactions |
ISO |
ebselen binds to and results in decreased activity of EPHX2 protein |
CTD |
PMID:23219563 |
|
NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [FMR1 5' UTR mutant form results in decreased activity of CS protein] |
CTD |
PMID:27385396 |
|
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein] |
CTD |
PMID:14572605 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Cisplatin results in increased activity of G6PC1 protein] |
CTD |
PMID:32860823 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gck |
glucokinase |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in increased activity of GCK protein |
CTD |
PMID:23795780 |
|
NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases phosphorylation |
EXP |
ebselen results in increased phosphorylation of GFAP protein |
CTD |
PMID:27282967 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 mRNA]; ebselen inhibits the reaction [Oxygen deficiency results in increased expression of GJA1 protein] |
CTD |
PMID:12958040 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] ebselen inhibits the reaction [Methylmercury Compounds results in decreased activity of GPX1 protein] |
CTD |
PMID:23795780 PMID:28383113 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
increases activity multiple interactions |
EXP |
ebselen results in increased activity of GSR protein ebselen inhibits the reaction [sodium arsenite results in decreased activity of GSR protein] |
CTD |
PMID:27282967 PMID:30558456 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
|
|
G |
Gsta3 |
glutathione S-transferase alpha 3 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of [GSTA1 protein binds to GSTA3 protein]; ebselen binds to and results in decreased activity of GSTA3 protein |
CTD |
PMID:8147899 |
|
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] |
CTD |
PMID:8147899 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
ebselen binds to and results in decreased activity of GSTP1 protein |
CTD |
PMID:8147899 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [Acetylcysteine inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased activity of HIF1A protein]]; ebselen inhibits the reaction [glutathione glycylethyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A mRNA]] |
CTD |
PMID:19374849 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[ebselen affects the abundance of Reactive Oxygen Species] which results in decreased expression of HMOX1 protein; [ebselen affects the abundance of Reactive Oxygen Species] which results in increased activity of HMOX1 protein |
CTD |
PMID:16959961 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
increases expression |
ISO |
ebselen results in increased expression of HPGDS mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
ebselen results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] |
CTD |
PMID:12794164 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
ebselen inhibits the reaction [sodium arsenite results in increased expression of IL6 protein] |
CTD |
PMID:30558456 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
ISO |
ebselen inhibits the reaction [GPX1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; ebselen promotes the reaction [Glucose results in increased secretion of INS1 protein] |
CTD |
PMID:23795780 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases activity increases phosphorylation |
ISO EXP |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen results in increased activity of MAPK1 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK1 protein] ebselen analog results in increased phosphorylation of MAPK1 protein; ebselen results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases activity increases phosphorylation |
ISO EXP |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] ebselen results in increased activity of MAPK3 protein ebselen analog results in increased phosphorylation of MAPK3 protein; ebselen results in increased phosphorylation of MAPK3 protein ebselen inhibits the reaction [Methylmercury Compounds results in increased phosphorylation of MAPK3 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; ebselen inhibits the reaction [tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 PMID:21300091 PMID:21960664 PMID:22001386 PMID:27282967 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation |
EXP |
ebselen results in increased phosphorylation of MAPK9 protein |
CTD |
PMID:27282967 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP13 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO |
ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [NGF protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions decreases activity |
ISO EXP |
ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; ebselen inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein] ebselen results in decreased activity of NOS2 protein |
CTD |
PMID:7590103 PMID:12794164 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases activity |
EXP |
ebselen results in decreased activity of NQO1 protein |
CTD |
PMID:7590103 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in increased expression of PDX1 protein |
CTD |
PMID:23795780 |
|
NCBI chr12:7,757,865...7,763,064
Ensembl chr12:7,757,865...7,763,064
|
|
G |
Phospho1 |
phosphoethanolamine/phosphocholine phosphatase 1 |
decreases activity |
ISO |
ebselen results in decreased activity of PHOSPHO1 protein |
CTD |
PMID:17227223 |
|
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
ebselen inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; ebselen inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein] |
CTD |
PMID:14572605 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Slc11a2 |
solute carrier family 11 member 2 |
multiple interactions |
ISO |
ebselen inhibits the reaction [SLC11A2 protein results in increased uptake of Iron] |
CTD |
PMID:16984886 |
|
NCBI chr 7:131,503,076...131,540,246
Ensembl chr 7:131,503,081...131,540,145
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions |
ISO EXP |
[ebselen co-treated with Glucose] results in increased expression of SLC2A2 protein ebselen inhibits the reaction [Cisplatin results in increased expression of SLC2A2 protein] |
CTD |
PMID:23795780 PMID:32860823 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:21131394 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases response to substance multiple interactions |
ISO |
ebselen results in decreased susceptibility to SOD1 protein mutant form ebselen inhibits the reaction [SOD1 gene mutant form inhibits the reaction [Glucose results in increased secretion of INS1 protein]] |
CTD |
PMID:16702190 PMID:23795780 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; ebselen inhibits the reaction [SOD2 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:20495008 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
EXP |
ebselen inhibits the reaction [Cisplatin results in increased activity of TAT protein] |
CTD |
PMID:32860823 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] ebselen inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; ebselen inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:11903743 PMID:16757516 PMID:21131394 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
ebselen inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA] |
CTD |
PMID:11903743 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
ebselen inhibits the reaction [sodium arsenite results in increased expression of TNF protein] |
CTD |
PMID:30558456 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
ISO |
ebselen results in increased expression of and results in increased activity of TXNRD1 protein |
CTD |
PMID:28383113 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
ISO |
[ebselen co-treated with Glucose] results in decreased expression of UCP2 protein |
CTD |
PMID:23795780 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases phosphorylation |
EXP |
ebselen results in increased phosphorylation of XBP1 protein |
CTD |
PMID:27282967 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Xpa |
XPA, DNA damage recognition and repair factor |
multiple interactions |
ISO |
ebselen inhibits the reaction [Zinc binds to XPA protein] |
CTD |
PMID:15265038 |
|
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
|
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions affects expression decreases expression |
ISO |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mRNA] methylselenic acid affects the expression of ABCC4 mRNA |
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Acp3 |
acid phosphatase 3 |
affects expression |
ISO |
methylselenic acid affects the expression of ACP3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:104,905,570...104,956,146
Ensembl chr 8:104,905,586...104,954,236
|
|
G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
affects expression decreases expression |
ISO |
methylselenic acid affects the expression of ACSL3 mRNA methylselenic acid results in decreased expression of ACSL3 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 9:80,115,164...80,164,636
Ensembl chr 9:80,115,112...80,164,627
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
increases expression |
ISO |
methylselenic acid results in increased expression of ACTA2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Actg2 |
actin gamma 2, smooth muscle |
increases expression |
ISO |
methylselenic acid results in increased expression of ACTG2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
|
|
G |
Adam22 |
ADAM metallopeptidase domain 22 |
increases expression |
ISO |
methylselenic acid results in increased expression of ADAM22 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962
|
|
G |
Add3 |
adducin 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of ADD3 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
increases expression |
ISO |
methylselenic acid results in increased expression of ADGRL3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
ISO |
methylselenic acid results in increased expression of AHR mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akap12 |
A-kinase anchoring protein 12 |
increases expression |
ISO |
methylselenic acid results in increased expression of AKAP12 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
increases expression |
ISO |
methylselenic acid results in increased expression of AKR1B1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases response to substance decreases phosphorylation |
ISO |
[methylselenic acid results in decreased phosphorylation of AKT1 protein] which results in increased susceptibility to Doxorubicin; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] AKT1 protein results in decreased susceptibility to methylselenic acid |
CTD |
PMID:15845651 PMID:17339365 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of AKT2 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Alad |
aminolevulinate dehydratase |
increases expression |
ISO |
methylselenic acid results in increased expression of ALAD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ALG3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
|
|
G |
Alg8 |
ALG8, alpha-1,3-glucosyltransferase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ALG8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:151,684,344...151,704,310
Ensembl chr 1:151,684,396...151,704,302
|
|
G |
Amt |
aminomethyltransferase |
increases expression |
ISO |
methylselenic acid results in increased expression of AMT mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:108,981,620...108,988,127
Ensembl chr 8:108,976,472...108,988,126
|
|
G |
Ank2 |
ankyrin 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of ANK2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
|
|
G |
Ank3 |
ankyrin 3 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ANK3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
|
|
G |
Apod |
apolipoprotein D |
affects expression |
ISO |
methylselenic acid affects the expression of APOD mRNA |
CTD |
PMID:14617803 |
|
NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305
|
|
G |
Ar |
androgen receptor |
affects response to substance increases degradation decreases expression decreases activity multiple interactions |
ISO |
AR protein affects the susceptibility to methylselenic acid methylselenic acid results in increased degradation of AR mRNA; methylselenic acid results in increased degradation of AR protein methylselenic acid results in decreased expression of AR mRNA; methylselenic acid results in decreased expression of AR protein methylselenic acid results in decreased activity of AR protein AR protein inhibits the reaction [methylselenic acid results in decreased expression of ABCC4 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of DHCR24 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of GUCY1A1 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK2 mRNA]; AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK3 mRNA]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to KLK3 promoter]]; Superoxides promotes the reaction [methylselenic acid results in decreased expression of AR protein] |
CTD |
PMID:14617803 PMID:15141018 PMID:16020662 PMID:16648561 PMID:16928829 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgef2 |
Rho/Rac guanine nucleotide exchange factor 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of ARHGEF2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
|
|
G |
Arl4a |
ADP-ribosylation factor like GTPase 4A |
increases expression |
ISO |
methylselenic acid results in increased expression of ARL4A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:57,079,496...57,084,156
Ensembl chr 6:57,078,812...57,085,066
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
methylselenic acid results in increased phosphorylation of and results in increased activity of ATF2 protein |
CTD |
PMID:11830524 |
|
NCBI chr 3:58,718,323...58,795,280
Ensembl chr 3:58,718,332...58,795,236
|
|
G |
Atf3 |
activating transcription factor 3 |
affects expression |
ISO |
methylselenic acid affects the expression of ATF3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf5 |
activating transcription factor 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ATF5 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr 1:95,295,602...95,299,755
Ensembl chr 1:95,295,610...95,299,707
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
ISO |
methylselenic acid results in increased cleavage of and results in increased activity of ATF6 protein |
CTD |
PMID:16205645 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of ATP2A2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
|
|
G |
Atp2b4 |
ATPase plasma membrane Ca2+ transporting 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of ATP2B4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
|
|
G |
Aurka |
aurora kinase A |
affects expression decreases expression |
ISO |
methylselenic acid affects the expression of AURKA mRNA methylselenic acid results in decreased expression of AURKA mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
B4galt1 |
beta-1,4-galactosyltransferase 1 |
affects expression |
ISO |
methylselenic acid affects the expression of B4GALT1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 5:55,935,614...55,982,461
Ensembl chr 5:55,935,615...55,982,461
|
|
G |
Bach1 |
BTB domain and CNC homolog 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of BACH1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr11:26,939,429...26,974,876
Ensembl chr11:26,939,480...26,972,447
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression |
EXP |
methylselenic acid affects the expression of BAX protein |
CTD |
PMID:12017302 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of BBC3 mRNA |
CTD |
PMID:28161410 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression |
EXP |
methylselenic acid affects the expression of BCL2 protein |
CTD |
PMID:12017302 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
increases expression |
ISO |
methylselenic acid results in increased expression of BCL2A1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
multiple interactions increases cleavage increases expression |
ISO |
BCL2L11 protein affects the susceptibility to [Doxorubicin co-treated with methylselenic acid]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of BCL2L11 protein] methylselenic acid results in increased expression of BCL2L11 mRNA; methylselenic acid results in increased expression of BCL2L11 protein |
CTD |
PMID:17339365 PMID:18790785 PMID:28161410 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
affects expression |
ISO |
methylselenic acid affects the expression of BIRC2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
affects expression |
ISO |
methylselenic acid affects the expression of BIRC3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions decreases expression |
ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of BIRC5 protein; methylselenic acid inhibits the reaction [SP1 protein binds to BIRC5 promoter] methylselenic acid results in decreased expression of BIRC5 mRNA; methylselenic acid results in decreased expression of BIRC5 protein |
CTD |
PMID:12517777 PMID:17876054 PMID:18444175 PMID:18567002 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of BMP4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr15:19,618,538...19,633,494
Ensembl chr15:19,618,542...19,623,306
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
increases expression |
ISO |
methylselenic acid results in increased expression of BRCA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of BTG3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:17,030,156...17,046,069
Ensembl chr11:17,030,160...17,046,170
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
affects expression |
ISO |
methylselenic acid affects the expression of BUB1B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
C1qbp |
complement C1q binding protein |
decreases expression |
ISO |
methylselenic acid results in decreased expression of C1QBP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
|
|
G |
Cadm1 |
cell adhesion molecule 1 |
affects expression |
ISO |
methylselenic acid affects the expression of CADM1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
|
|
G |
Calm1 |
calmodulin 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of CALM1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
increases expression |
ISO |
methylselenic acid results in increased expression of CAMK2G mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
increases expression |
ISO |
methylselenic acid results in increased expression of CAMK4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr18:24,582,988...24,811,918
Ensembl chr18:24,585,269...24,802,487
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CAPZA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Casp12 |
caspase 12 |
multiple interactions increases cleavage |
ISO |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP12 protein] |
CTD |
PMID:16204082 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
ISO |
methylselenic acid results in increased cleavage of and results in increased activity of CASP3 protein methylselenic acid results in increased cleavage of CASP3 protein |
CTD |
PMID:19276161 PMID:28161410 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp4 |
caspase 4 |
increases cleavage |
ISO |
methylselenic acid results in increased cleavage of CASP4 protein |
CTD |
PMID:28161410 |
|
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
|
|
G |
Casp7 |
caspase 7 |
increases cleavage multiple interactions |
ISO |
methylselenic acid results in increased cleavage of CASP7 protein Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; methylselenic acid inhibits the reaction [CASP7 protein binds to HSPA5 protein]; Sodium Selenite inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of CASP7 protein] |
CTD |
PMID:16204082 PMID:18790785 PMID:28161410 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage |
ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP8 protein; [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP8 protein [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; methylselenic acid results in increased cleavage of CASP8 protein |
CTD |
PMID:18444175 PMID:18790785 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage increases expression |
ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of CASP9 protein; [[methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; [Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein; [methylselenic acid co-treated with Tamoxifen] results in increased cleavage of CASP9 protein; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased cleavage of and results in increased activity of CASP9 protein]; methylselenic acid results in increased cleavage of and results in increased activity of CASP9 protein [methylselenic acid results in increased cleavage of CASP9 protein] which results in increased cleavage of CASP8 protein; methylselenic acid results in increased cleavage of CASP9 protein methylselenic acid results in increased expression of CASP9 mRNA |
CTD |
PMID:12517777 PMID:17339365 PMID:18444175 PMID:18790785 PMID:28161410 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cast |
calpastatin |
increases expression |
ISO |
methylselenic acid results in increased expression of CAST mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:3,973,112...4,082,658
Ensembl chr 2:3,973,112...4,082,659
|
|
G |
Cbx7 |
chromobox 7 |
increases expression |
ISO |
methylselenic acid results in increased expression of CBX7 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Cck |
cholecystokinin |
increases expression |
ISO |
methylselenic acid results in increased expression of CCK mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:121,153,499...121,160,194
Ensembl chr 8:121,153,500...121,160,084
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CCNA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CCNB1 mRNA; methylselenic acid results in decreased expression of CCNB1 protein |
CTD |
PMID:11830524 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
affects expression decreases expression multiple interactions |
ISO EXP |
methylselenic acid affects the expression of CCND1 mRNA methylselenic acid affects the expression of CCND1 protein methylselenic acid results in decreased expression of CCND1 mRNA [2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CCND1 protein; KLF4 protein affects the reaction [methylselenic acid results in decreased expression of CCND1 mRNA]; methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein] |
CTD |
PMID:11830524 PMID:12017302 PMID:17847021 PMID:18314491 PMID:18444175 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne2 |
cyclin E2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CCNE2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cd14 |
CD14 molecule |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CD14 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
|
|
G |
Cd44 |
CD44 molecule |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CD44 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
|
|
G |
Cdc14b |
cell division cycle 14B |
affects expression |
ISO |
methylselenic acid affects the expression of CDC14B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr17:844,686...934,787
Ensembl chr17:844,685...933,235
|
|
G |
Cdc20 |
cell division cycle 20 |
affects expression |
ISO |
methylselenic acid affects the expression of CDC20 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
|
|
G |
Cdc25a |
cell division cycle 25A |
affects expression decreases expression |
ISO |
methylselenic acid affects the expression of CDC25A mRNA methylselenic acid results in decreased expression of CDC25A mRNA; methylselenic acid results in decreased expression of CDC25A protein |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CDC25C mRNA |
CTD |
PMID:11830524 |
|
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdc42 |
cell division cycle 42 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CDC42 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
|
|
G |
Cdc42ep3 |
CDC42 effector protein 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of CDC42EP3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:15,710,894...15,731,366
Ensembl chr 6:15,708,730...15,732,721
|
|
G |
Cdc6 |
cell division cycle 6 |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of CDC6 mRNA methylselenic acid affects the expression of CDC6 mRNA |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
|
|
G |
Cdh15 |
cadherin 15 |
increases expression |
ISO |
methylselenic acid results in increased expression of CDH15 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
|
|
G |
Cdh7 |
cadherin 7 |
increases expression |
ISO |
methylselenic acid results in increased expression of CDH7 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr13:26,672,058...26,821,571
Ensembl chr13:26,672,484...26,819,846
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions decreases expression |
ISO |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein] methylselenic acid results in decreased expression of CDK1 mRNA; methylselenic acid results in decreased expression of CDK1 protein |
CTD |
PMID:11830524 PMID:12517777 PMID:16205645 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CDK10 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
|
|
G |
Cdk16 |
cyclin-dependent kinase 16 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CDK16 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr X:1,492,814...1,504,309
Ensembl chr X:1,492,814...1,504,148
|
|
G |
Cdk18 |
cyclin-dependent kinase 18 |
increases expression |
ISO |
methylselenic acid results in increased expression of CDK18 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:43,555,597...43,582,210
Ensembl chr13:43,556,748...43,588,525
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions decreases expression |
ISO |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK2 protein]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] methylselenic acid results in decreased expression of CDK2 mRNA; methylselenic acid results in decreased expression of CDK2 protein |
CTD |
PMID:12517777 PMID:16205645 PMID:17847021 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions decreases expression |
ISO |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein] methylselenic acid results in decreased expression of CDK4 mRNA |
CTD |
PMID:11830524 PMID:12517777 PMID:17847021 PMID:18548127 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
increases expression |
ISO |
methylselenic acid results in increased expression of CDK5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
multiple interactions |
ISO |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK6 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK6 protein] |
CTD |
PMID:17847021 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkl1 |
cyclin dependent kinase like 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CDKL1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions affects expression increases expression |
ISO EXP |
DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in increased expression of and results in decreased degradation of CDKN1A protein methylselenic acid affects the expression of CDKN1A protein methylselenic acid results in increased expression of CDKN1A mRNA; methylselenic acid results in increased expression of CDKN1A protein methylselenic acid affects the expression of CDKN1A mRNA |
CTD |
PMID:12017302 PMID:12517777 PMID:14617803 PMID:16205645 PMID:17847021 PMID:18314491 More...
|
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions affects expression increases expression |
ISO EXP |
KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA]; methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein]; methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] methylselenic acid affects the expression of CDKN1B protein methylselenic acid results in increased expression of CDKN1B mRNA; methylselenic acid results in increased expression of CDKN1B protein |
CTD |
PMID:12017302 PMID:17847021 PMID:18314491 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
increases expression affects expression |
ISO |
methylselenic acid results in increased expression of CDKN1C mRNA methylselenic acid affects the expression of CDKN1C mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
multiple interactions increases expression |
ISO |
methylselenic acid promotes the reaction [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid promotes the reaction [CDKN2A protein binds to CDK6 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK4 protein binds to CCND1 protein]; methylselenic acid results in decreased activity of [CDKN2A protein binds to CDK6 protein] methylselenic acid results in increased expression of CDKN2A protein |
CTD |
PMID:17847021 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
affects expression increases expression |
ISO |
methylselenic acid affects the expression of CDKN2D mRNA methylselenic acid results in increased expression of CDKN2D mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
|
|
G |
Cenpa |
centromere protein A |
affects expression |
ISO |
methylselenic acid affects the expression of CENPA mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpf |
centromere protein F |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CENPF mRNA |
CTD |
PMID:12517777 |
|
NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
multiple interactions |
ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CFLAR protein |
CTD |
PMID:18444175 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chaf1a |
chromatin assembly factor 1 subunit A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CHAF1A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of CHEK2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Clu |
clusterin |
affects expression |
ISO |
methylselenic acid affects the expression of CLU mRNA |
CTD |
PMID:14617803 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cnpy2 |
canopy FGF signaling regulator 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CNPY2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
|
|
G |
Col16a1 |
collagen type XVI alpha 1 chain |
increases expression |
ISO |
methylselenic acid results in increased expression of COL16A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:142,388,376...142,442,825
Ensembl chr 5:142,388,426...142,442,825
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases expression |
ISO |
methylselenic acid results in increased expression of COL6A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Coro1a |
coronin 1A |
increases expression |
ISO |
methylselenic acid results in increased expression of CORO1A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of CRABP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of CREB1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Creb3l1 |
cAMP responsive element binding protein 3-like 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of CREB3L1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:77,952,589...77,993,513
Ensembl chr 3:77,952,540...77,993,456
|
|
G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
affects expression |
ISO |
methylselenic acid affects the expression of CREB3L4 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932
|
|
G |
Cryab |
crystallin, alpha B |
increases expression |
ISO |
methylselenic acid results in increased expression of CRYAB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csrp1 |
cysteine and glycine-rich protein 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of CSRP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
|
|
G |
Ctsk |
cathepsin K |
increases expression |
ISO |
methylselenic acid results in increased expression of CTSK mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Cul1 |
cullin 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of CUL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:76,551,952...76,625,830
Ensembl chr 4:76,551,983...76,627,980
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
increases expression |
ISO |
methylselenic acid results in increased expression of CYLD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of DDIT3 protein] methylselenic acid results in increased expression of DDIT3 mRNA; methylselenic acid results in increased expression of DDIT3 protein |
CTD |
PMID:11830524 PMID:12517777 PMID:16204082 PMID:16205645 PMID:19276161 PMID:28161410 More...
|
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Deaf1 |
DEAF1 transcription factor |
decreases expression |
ISO |
methylselenic acid results in decreased expression of DEAF1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:196,401,857...196,435,541
Ensembl chr 1:196,401,857...196,435,541
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions decreases expression |
ISO |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of DHCR24 mRNA] |
CTD |
PMID:16020662 PMID:18548127 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dhfr |
dihydrofolate reductase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of DHFR mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
|
|
G |
Dixdc1 |
DIX domain containing 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of DIXDC1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
|
|
G |
Dkc1 |
dyskerin pseudouridine synthase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of DKC1 mRNA |
CTD |
PMID:18548127 |
|
|
|
G |
Dlc1 |
DLC1 Rho GTPase activating protein |
increases expression |
ISO |
methylselenic acid results in increased expression of DLC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:55,246,716...55,671,441
Ensembl chr16:55,291,584...55,671,439
|
|
G |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
increases expression |
ISO |
methylselenic acid results in increased expression of DNAJB5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
affects expression |
ISO |
methylselenic acid affects the expression of DNAJB9 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of DNPH1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
increases expression |
ISO |
methylselenic acid results in increased expression of DPYD mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of DPYSL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
|
|
G |
Dtna |
dystrobrevin, alpha |
increases expression |
ISO |
methylselenic acid results in increased expression of DTNA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:14,687,193...14,944,232
Ensembl chr18:14,587,852...14,944,261
|
|
G |
Dtymk |
deoxythymidylate kinase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of DTYMK mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 9:94,315,552...94,324,386
Ensembl chr 9:94,315,552...94,324,870
|
|
G |
Dusp10 |
dual specificity phosphatase 10 |
increases expression |
ISO |
methylselenic acid results in increased expression of DUSP10 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr13:95,613,716...95,651,716
Ensembl chr13:95,614,292...95,651,716
|
|
G |
Dvl3 |
dishevelled segment polarity protein 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of DVL3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462
|
|
G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of DYNC1I1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:33,852,597...34,166,159
Ensembl chr 4:33,852,927...34,166,149
|
|
G |
E2f1 |
E2F transcription factor 1 |
affects expression multiple interactions decreases expression |
ISO |
methylselenic acid affects the expression of E2F1 mRNA methylselenic acid promotes the reaction [E2F1 protein binds to RB1 protein] methylselenic acid results in decreased expression of E2F1 mRNA; methylselenic acid results in decreased expression of E2F1 protein |
CTD |
PMID:11830524 PMID:14617803 PMID:17847021 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
E2f5 |
E2F transcription factor 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of E2F5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 2:86,997,331...87,012,908
Ensembl chr 2:86,997,332...87,012,990
|
|
G |
Eci1 |
enoyl-CoA delta isomerase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ECI1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:13,456,715...13,470,061
Ensembl chr10:13,456,563...13,470,061
|
|
G |
Ecm2 |
extracellular matrix protein 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of ECM2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:15,120,194...15,152,536
Ensembl chr17:15,120,196...15,152,516
|
|
G |
Ednra |
endothelin receptor type A |
increases expression |
ISO |
methylselenic acid results in increased expression of EDNRA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
|
|
G |
Ednrb |
endothelin receptor type B |
increases expression |
ISO |
methylselenic acid results in increased expression of EDNRB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Efemp2 |
EGF containing fibulin extracellular matrix protein 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of EFEMP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
|
|
G |
Egr1 |
early growth response 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of EGR1 mRNA |
CTD |
PMID:11172735 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
multiple interactions increases phosphorylation |
ISO |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:16204082 |
|
NCBI chr 2:142,761,303...142,794,767
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
ISO |
HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2AK3 protein]; methylselenic acid results in increased phosphorylation of and results in increased activity of EIF2AK3 protein |
CTD |
PMID:16204082 PMID:16205645 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of EIF4G2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588
|
|
G |
Elf3 |
E74 like ETS transcription factor 3 |
increases expression affects expression |
ISO |
methylselenic acid results in increased expression of ELF3 mRNA methylselenic acid affects the expression of ELF3 mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
|
|
G |
Eno2 |
enolase 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of ENO2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
|
|
G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of EPB41L2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
|
|
G |
Eps8 |
EGFR pathway substrate 8, signaling adaptor |
increases expression |
ISO |
methylselenic acid results in increased expression of EPS8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:170,388,378...170,486,873
Ensembl chr 4:170,388,378...170,486,873
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
ISO |
methylselenic acid results in increased expression of ERCC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions decreases expression |
ISO |
[methylselenic acid co-treated with afimoxifene] results in decreased expression of ESR1 mRNA; [methylselenic acid co-treated with afimoxifene] results in decreased expression of ESR1 protein; methylselenic acid inhibits the reaction [Estradiol binds to ESR1 protein]; methylselenic acid results in decreased expression of and results in decreased activity of ESR1 protein methylselenic acid results in decreased expression of ESR1 mRNA; methylselenic acid results in decreased expression of ESR1 protein |
CTD |
PMID:15833885 PMID:16093440 PMID:16155795 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression affects expression |
ISO |
methylselenic acid results in increased expression of ESR2 mRNA methylselenic acid affects the expression of ESR2 mRNA |
CTD |
PMID:15833885 PMID:16928829 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Etv5 |
ETS variant transcription factor 5 |
increases expression |
ISO |
methylselenic acid results in increased expression of ETV5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:78,608,618...78,666,221
Ensembl chr11:78,608,710...78,666,215
|
|
G |
Etv6 |
ETS variant transcription factor 6 |
increases expression |
ISO |
methylselenic acid results in increased expression of ETV6 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:166,849,031...167,085,211
Ensembl chr 4:166,847,686...167,084,992
|
|
G |
Ext1 |
exostosin glycosyltransferase 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of EXT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:84,375,769...84,654,625
Ensembl chr 7:84,375,784...84,655,357
|
|
G |
Fam107a |
family with sequence similarity 107, member A |
increases expression |
ISO |
methylselenic acid results in increased expression of FAM107A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
|
|
G |
Fbxl8 |
F-box and leucine-rich repeat protein 8 |
increases expression |
ISO |
methylselenic acid results in increased expression of FBXL8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr19:33,142,705...33,147,266
Ensembl chr19:33,142,715...33,147,262
|
|
G |
Fermt2 |
FERM domain containing kindlin 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of FERMT2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
|
|
G |
Fez1 |
fasciculation and elongation protein zeta 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of FEZ1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of FGF2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fhl2 |
four and a half LIM domains 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of FHL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of FKBP4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
affects expression |
ISO |
methylselenic acid affects the expression of FKBP5 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Flnc |
filamin C |
increases expression |
ISO |
methylselenic acid results in increased expression of FLNC mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
|
|
G |
Fn1 |
fibronectin 1 |
affects expression |
ISO |
methylselenic acid affects the expression of FN1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fnbp1 |
formin binding protein 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of FNBP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881
|
|
G |
Foxa1 |
forkhead box A1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of FOXA1 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxo3 |
forkhead box O3 |
multiple interactions |
ISO |
methylselenic acid results in decreased phosphorylation of and results in increased activity of FOXO3 protein |
CTD |
PMID:17339365 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
increases expression |
ISO |
methylselenic acid results in increased expression of FYN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
|
|
G |
Gabarapl1 |
GABA type A receptor associated protein like 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of GABARAPL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:162,980,309...162,989,452
Ensembl chr 4:162,980,249...162,989,450
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
methylselenic acid results in increased expression of GADD45A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of GALNT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
|
|
G |
Gas1 |
growth arrest-specific 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of GAS1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:4,482,168...4,485,153
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of GATD3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gbp2 |
guanylate binding protein 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of GBP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of GJA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Gpr161 |
G protein-coupled receptor 161 |
increases expression |
ISO |
methylselenic acid results in increased expression of GPR161 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:77,578,257...77,623,661
Ensembl chr13:77,577,739...77,619,613
|
|
G |
Gpr37 |
G protein-coupled receptor 37 |
increases expression |
ISO |
methylselenic acid results in increased expression of GPR37 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:54,138,860...54,160,927
Ensembl chr 4:54,138,870...54,161,001
|
|
G |
Grk5 |
G protein-coupled receptor kinase 5 |
increases expression |
ISO |
methylselenic acid results in increased expression of GRK5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:260,028,269...260,223,699
Ensembl chr 1:260,028,242...260,218,701
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions decreases phosphorylation |
ISO |
methylselenic acid inhibits the reaction [Doxorubicin results in increased phosphorylation of GSK3B protein] methylselenic acid results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:17339365 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsn |
gelsolin |
increases expression |
ISO |
methylselenic acid results in increased expression of GSN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
|
|
G |
Gtf3c1 |
general transcription factor IIIC subunit 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of GTF3C1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:180,203,995...180,270,201
Ensembl chr 1:180,203,995...180,270,201
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
affects expression decreases expression multiple interactions |
ISO |
methylselenic acid affects the expression of GUCY1A1 mRNA methylselenic acid results in decreased expression of GUCY1A1 mRNA AR protein inhibits the reaction [methylselenic acid results in decreased expression of GUCY1A1 mRNA] |
CTD |
PMID:14617803 PMID:16020662 PMID:18548127 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
H1f0 |
H1.0 linker histone |
affects expression |
ISO |
methylselenic acid affects the expression of H1-0 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 7:110,592,834...110,594,694
Ensembl chr 7:110,592,208...110,594,694
|
|
G |
H2ac18 |
H2A clustered histone 18 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of H2AC18 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:183,808,398...183,808,992
|
|
G |
Habp4 |
hyaluronan binding protein 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of HABP4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:934,931...957,604
Ensembl chr17:935,654...957,565
|
|
G |
Hacd2 |
3-hydroxyacyl-CoA dehydratase 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of HACD2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:65,667,671...65,762,903
Ensembl chr11:65,670,281...65,762,889
|
|
G |
Heph |
hephaestin |
increases expression |
ISO |
methylselenic acid results in increased expression of HEPH mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:61,151,131...61,402,980
Ensembl chr X:61,296,345...61,402,980
|
|
G |
Hist1h2af |
histone cluster 1 H2A family member F |
decreases expression |
ISO |
methylselenic acid results in decreased expression of H2AC8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
|
|
G |
Hmgn2-ps3 |
high mobility group nucleosomal binding domain 2, pseudogene 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of HMGN4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:99,990,743...99,991,003
Ensembl chr 3:99,990,743...99,991,003
|
|
G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
decreases expression |
ISO |
methylselenic acid results in decreased expression of HNRNPAB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
|
|
G |
Hoxa9 |
homeobox A9 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of HOXA9 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:81,323,235...81,329,344
Ensembl chr 4:81,323,382...81,326,358
|
|
G |
Hoxd8 |
homeobox D8 |
increases expression |
ISO |
methylselenic acid results in increased expression of HOXD8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:59,607,793...59,610,359
Ensembl chr 3:59,607,996...59,610,361
|
|
G |
Hpgd |
15-hydroxyprostaglandin dehydrogenase |
increases expression |
ISO |
methylselenic acid results in increased expression of HPGD mRNA; methylselenic acid results in increased expression of HPGD protein |
CTD |
PMID:25187657 |
|
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
|
|
G |
Hpgds |
hematopoietic prostaglandin D synthase |
increases expression |
ISO |
methylselenic acid results in increased expression of HPGDS mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:94,373,342...94,397,883
|
|
G |
Hsp90b1 |
heat shock protein 90 beta family member 1 |
increases expression multiple interactions |
ISO |
methylselenic acid results in increased expression of HSP90B1 protein HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSP90B1 protein] |
CTD |
PMID:16204082 |
|
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
|
|
G |
Hspa4l |
heat shock protein family A (Hsp70) member 4 like |
increases expression |
ISO |
methylselenic acid results in increased expression of HSPA4L mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
ISO |
HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK1 protein]; HSPA5 protein affects the reaction [methylselenic acid results in decreased expression of CDK2 protein]; HSPA5 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP12 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of DDIT3 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSP90B1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased expression of HSPA5 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2A protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased phosphorylation of EIF2AK3 protein]; methylselenic acid inhibits the reaction [CASP7 protein binds to HSPA5 protein] methylselenic acid results in increased expression of HSPA5 mRNA; methylselenic acid results in increased expression of HSPA5 protein |
CTD |
PMID:16204082 PMID:16205645 PMID:28161410 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ID1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Id2 |
inhibitor of DNA binding 2 |
affects expression |
ISO |
methylselenic acid affects the expression of ID2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression increases expression |
ISO |
methylselenic acid results in decreased expression of ID3 mRNA methylselenic acid results in increased expression of ID3 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ids |
iduronate 2-sulfatase |
increases expression |
ISO |
methylselenic acid results in increased expression of IDS mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:149,025,976...149,046,641
Ensembl chr X:149,025,976...149,046,663
|
|
G |
Ifrd2 |
interferon-related developmental regulator 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of IFRD2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:108,260,969...108,266,191
Ensembl chr 8:108,260,969...108,266,194
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of IGF1 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igsf3 |
immunoglobulin superfamily, member 3 |
affects expression |
ISO |
methylselenic acid affects the expression of IGSF3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:188,811,394...188,899,645
Ensembl chr 2:188,811,380...188,899,645
|
|
G |
Ing1 |
inhibitor of growth family, member 1 |
affects expression |
ISO |
methylselenic acid affects the expression of ING1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr16:77,937,276...77,945,320
Ensembl chr16:77,937,279...77,946,264
|
|
G |
Inpp4b |
inositol polyphosphate-4-phosphatase type II B |
affects expression |
ISO |
methylselenic acid affects the expression of INPP4B mRNA |
CTD |
PMID:14617803 |
|
NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
|
|
G |
Ipo8 |
importin 8 |
increases expression |
ISO |
methylselenic acid results in increased expression of IPO8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:181,729,216...181,793,672
Ensembl chr 4:181,729,220...181,793,161
|
|
G |
Irf1 |
interferon regulatory factor 1 |
affects expression |
ISO |
methylselenic acid affects the expression of IRF1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Itga3 |
integrin subunit alpha 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of ITGA3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ITGB1 mRNA |
CTD |
PMID:11172735 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb3bp |
integrin subunit beta 3 binding protein |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ITGB3BP mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
|
|
G |
Itgb4 |
integrin subunit beta 4 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ITGB4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Itgb5 |
integrin subunit beta 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ITGB5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr11:66,828,428...66,944,231
Ensembl chr11:66,829,285...66,944,472
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of ITPR1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
|
|
G |
Jak1 |
Janus kinase 1 |
affects expression increases expression |
ISO |
methylselenic acid affects the expression of JAK1 mRNA methylselenic acid results in increased expression of JAK1 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of JUN protein methylselenic acid affects the expression of JUN mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
methylselenic acid results in decreased expression of JUNB mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kcnab1 |
potassium voltage-gated channel subfamily A regulatory beta subunit 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of KCNAB1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:149,137,025...149,603,540
Ensembl chr 2:149,137,041...149,603,534
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of KCNH2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
increases expression |
ISO |
methylselenic acid results in increased expression of KCNJ8 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:175,508,908...175,515,829
Ensembl chr 4:175,508,912...175,515,603
|
|
G |
Kdelr2 |
KDEL endoplasmic reticulum protein retention receptor 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of KDELR2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:11,138,820...11,157,117
Ensembl chr12:11,138,820...11,157,153
|
|
G |
Kif11 |
kinesin family member 11 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of KIF11 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
|
|
G |
Kif20b |
kinesin family member 20B |
decreases expression |
ISO |
methylselenic acid results in decreased expression of KIF20B mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:232,428,293...232,483,798
Ensembl chr 1:232,428,371...232,483,787
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions increases expression increases activity affects expression |
ISO |
KLF4 protein affects the reaction [methylselenic acid results in decreased expression of CCND1 mRNA]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA]; KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA] methylselenic acid results in increased expression of KLF4 mRNA methylselenic acid results in increased activity of KLF4 protein methylselenic acid affects the expression of KLF4 mRNA |
CTD |
PMID:14617803 PMID:18314491 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klhl2 |
kelch-like family member 2 |
affects expression |
ISO |
methylselenic acid affects the expression of KLHL2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr16:24,860,744...24,973,348
Ensembl chr16:24,860,667...24,973,341
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions decreases expression affects expression decreases secretion |
ISO |
AR protein inhibits the reaction [methylselenic acid results in decreased expression of KLK3 mRNA]; methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [AR protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA1 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA2 protein binds to KLK3 promoter]]; methylselenic acid inhibits the reaction [mibolerone results in increased expression of KLK3 mRNA]; methylselenic acid results in increased degradation of and results in decreased expression of and results in decreased secretion of KLK3 protein methylselenic acid results in decreased expression of KLK3 mRNA; methylselenic acid results in decreased expression of KLK3 protein methylselenic acid affects the expression of KLK3 mRNA methylselenic acid results in decreased secretion of KLK3 protein |
CTD |
PMID:14617803 PMID:15141018 PMID:16020662 PMID:16648561 PMID:16928829 PMID:18548127 More...
|
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Krt15 |
keratin 15 |
increases expression |
ISO |
methylselenic acid results in increased expression of KRT15 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt20 |
keratin 20 |
increases expression |
ISO |
methylselenic acid results in increased expression of KRT20 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,384,802...84,394,107
|
|
G |
Lage3 |
L antigen family, member 3 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of LAGE3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:152,138,209...152,139,632
Ensembl chr X:152,138,218...152,139,632
|
|
G |
Lama4 |
laminin subunit alpha 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of LAMA4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
|
|
G |
Lamb3 |
laminin subunit beta 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of LAMB3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405
|
|
G |
Lmnb2 |
lamin B2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of LMNB2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 7:8,792,628...8,808,665
Ensembl chr 7:8,789,314...8,808,665
|
|
G |
Lypla1 |
lysophospholipase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of LYPLA1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:14,679,605...14,708,774
Ensembl chr 5:14,679,606...14,708,746
|
|
G |
Maea |
macrophage erythroblast attacher, E3 ubiquitin ligase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MAEA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
|
|
G |
Maf |
MAF bZIP transcription factor |
increases expression |
ISO |
methylselenic acid results in increased expression of MAF mRNA |
CTD |
PMID:18548127 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Map1b |
microtubule-associated protein 1B |
affects expression increases expression |
ISO |
methylselenic acid affects the expression of MAP1B mRNA methylselenic acid results in increased expression of MAP1B mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 2:30,817,261...30,910,458
Ensembl chr 2:30,817,261...30,910,317
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
decreases expression increases expression |
ISO |
methylselenic acid results in decreased expression of MAP2K1 mRNA methylselenic acid results in increased expression of MAP2K1 mRNA |
CTD |
PMID:11830524 PMID:12517777 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
increases expression |
ISO |
methylselenic acid results in increased expression of MAP2K5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 8:63,625,220...63,852,090
Ensembl chr 8:63,625,221...63,851,983
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
methylselenic acid results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:15845651 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases expression increases phosphorylation |
ISO |
methylselenic acid results in increased expression of MAPK3 mRNA methylselenic acid results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:11830524 PMID:15845651 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression |
ISO |
methylselenic acid results in increased expression of MAPK8 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MAPK9 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mapre2 |
microtubule-associated protein, RP/EB family, member 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of MAPRE2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:15,028,675...15,169,553
Ensembl chr18:15,029,041...15,168,044
|
|
G |
Mapt |
microtubule-associated protein tau |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MAPT mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Maz |
MYC associated zinc finger protein |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MAZ mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:181,629,742...181,635,193
Ensembl chr 1:181,629,729...181,650,408
|
|
G |
Mbnl2 |
muscleblind-like splicing regulator 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of MBNL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:97,385,278...97,542,924
Ensembl chr15:97,385,244...97,542,937
|
|
G |
Mccc2 |
methylcrotonyl-CoA carboxylase subunit 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MCCC2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
|
|
G |
Mcm2 |
minichromosome maintenance complex component 2 |
affects expression |
ISO |
methylselenic acid affects the expression of MCM2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
|
|
G |
Mcm3 |
minichromosome maintenance complex component 3 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MCM3 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
|
|
G |
Mcm5 |
minichromosome maintenance complex component 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MCM5 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of MCM6 mRNA methylselenic acid affects the expression of MCM6 mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960
|
|
G |
Mcm7 |
minichromosome maintenance complex component 7 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MCM7 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of ME1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mef2c |
myocyte enhancer factor 2C |
increases expression |
ISO |
methylselenic acid results in increased expression of MEF2C mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:13,973,299...14,136,065
Ensembl chr 2:13,993,438...14,132,880
|
|
G |
Men1 |
menin 1 |
affects expression |
ISO |
methylselenic acid affects the expression of MEN1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:203,638,905...203,644,871
Ensembl chr 1:203,639,000...203,644,871
|
|
G |
Micu2 |
mitochondrial calcium uptake 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MICU2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:32,064,872...32,146,874
Ensembl chr15:32,064,875...32,147,094
|
|
G |
Mitf |
melanocyte inducing transcription factor |
increases expression |
ISO |
methylselenic acid results in increased expression of MITF mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MKI67 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MRPL19 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:114,521,824...114,526,053
Ensembl chr 4:114,521,824...114,526,053
|
|
G |
Mxd1 |
max dimerization protein 1 |
affects expression |
ISO |
methylselenic acid affects the expression of MXD1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
increases expression |
ISO |
methylselenic acid results in increased expression of MXI1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Mybl2 |
MYB proto-oncogene like 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MYBL2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
affects expression multiple interactions |
ISO |
methylselenic acid affects the expression of MYC mRNA methylselenic acid inhibits the reaction [afimoxifene results in increased expression of MYC mRNA]; methylselenic acid inhibits the reaction [Estradiol results in increased expression of MYC mRNA] |
CTD |
PMID:14617803 PMID:15833885 PMID:16093440 PMID:16155795 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myl9 |
myosin light chain 9 |
increases expression |
ISO |
methylselenic acid results in increased expression of MYL9 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Myo10 |
myosin X |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MYO10 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
|
|
G |
Myrip |
myosin VIIA and Rab interacting protein |
decreases expression |
ISO |
methylselenic acid results in decreased expression of MYRIP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:120,017,749...120,184,821
Ensembl chr 8:120,017,524...120,183,833
|
|
G |
Naaa |
N-acylethanolamine acid amidase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of NAAA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:15,777,306...15,796,411
Ensembl chr14:15,777,306...15,796,410
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA1 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [Dihydrotestosterone promotes the reaction [NCOA2 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR1 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr10:46,999,536...47,142,294
Ensembl chr10:46,999,536...47,141,032
|
|
G |
Ncor2 |
nuclear receptor co-repressor 2 |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [Dihydrotestosterone inhibits the reaction [NCOR2 protein binds to KLK3 promoter]] |
CTD |
PMID:16648561 |
|
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
affects expression |
ISO |
methylselenic acid affects the expression of NDRG1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nebl |
nebulette |
increases expression |
ISO |
methylselenic acid results in increased expression of NEBL mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:80,113,891...80,466,331
Ensembl chr17:80,118,543...80,466,210
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
affects expression |
ISO |
methylselenic acid affects the expression of NFIL3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of NFKB1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
affects expression |
ISO |
methylselenic acid affects the expression of NKX3-1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
|
|
G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of NME1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
|
|
G |
Nme4 |
NME/NM23 nucleoside diphosphate kinase 4 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of NME4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479
|
|
G |
Nmi |
N-myc (and STAT) interactor |
decreases expression |
ISO |
methylselenic acid results in decreased expression of NMI mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:36,415,607...36,439,716
Ensembl chr 3:36,415,607...36,439,498
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
ISO |
methylselenic acid results in increased activity of NQO1 protein |
CTD |
PMID:14617803 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
affects expression |
ISO |
methylselenic acid affects the expression of NR3C1 mRNA |
CTD |
PMID:16928829 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Oat |
ornithine aminotransferase |
increases expression |
ISO |
methylselenic acid results in increased expression of OAT mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
|
|
G |
Olfml2a |
olfactomedin-like 2A |
increases expression |
ISO |
methylselenic acid results in increased expression of OLFML2A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:22,688,590...22,717,917
Ensembl chr 3:22,688,598...22,717,909
|
|
G |
Optn |
optineurin |
increases expression |
ISO |
methylselenic acid results in increased expression of OPTN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:73,209,572...73,260,251
Ensembl chr17:73,209,575...73,260,251
|
|
G |
Pakap |
paralemmin A kinase anchor protein |
increases expression |
ISO |
methylselenic acid results in increased expression of PALM2AKAP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:72,536,986...72,648,524 NCBI chr 5:72,313,646...72,450,645
Ensembl chr 5:72,181,718...72,648,524
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in increased cleavage of PARP1 protein; [Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein; AKT1 protein modified form inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; BCL2L11 protein promotes the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of PARP1 protein]; SB 216763 inhibits the reaction [[Doxorubicin co-treated with methylselenic acid] results in increased degradation of PARP1 protein] |
CTD |
PMID:15845651 PMID:16204082 PMID:17339365 PMID:18444175 PMID:19276161 PMID:28161410 More...
|
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Patz1 |
POZ (BTB) and AT hook containing zinc finger 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PATZ1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr14:78,154,590...78,173,032
Ensembl chr14:78,152,516...78,173,032
|
|
G |
Paxip1 |
PAX interacting protein 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PAXIP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:7,525,132...7,576,659
Ensembl chr 4:7,525,004...7,576,548
|
|
G |
Pbx1 |
PBX homeobox 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of PBX1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:80,278,766...80,588,563
Ensembl chr13:80,278,770...80,588,594
|
|
G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PCBD1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
|
|
G |
Pcna |
proliferating cell nuclear antigen |
affects expression decreases expression |
ISO |
methylselenic acid affects the expression of PCNA mRNA methylselenic acid results in decreased expression of PCNA mRNA |
CTD |
PMID:11830524 PMID:12517777 PMID:14617803 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Peg3 |
paternally expressed 3 |
affects expression |
ISO |
methylselenic acid affects the expression of PEG3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:67,097,874...67,124,692
Ensembl chr 1:67,097,904...67,124,671
|
|
G |
Pfdn5 |
prefoldin subunit 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PFDN5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
|
|
G |
Pgap2 |
post-GPI attachment to proteins 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PGAP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
|
|
G |
Pgm5 |
phosphoglucomutase 5 |
increases expression |
ISO |
methylselenic acid results in increased expression of PGM5 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:222,325,638...222,513,434
Ensembl chr 1:222,325,643...222,513,437
|
|
G |
Pgr |
progesterone receptor |
affects expression |
ISO |
methylselenic acid affects the expression of PGR mRNA |
CTD |
PMID:16928829 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pja2 |
praja ring finger ubiquitin ligase 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of PJA2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:103,956,678...104,006,763
Ensembl chr 9:103,956,678...104,006,783
|
|
G |
Pla2g4a |
phospholipase A2 group 4A |
increases expression |
ISO |
methylselenic acid results in increased expression of PLA2G4A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
|
|
G |
Plcb4 |
phospholipase C, beta 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of PLCB4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:122,952,965...123,322,522
Ensembl chr 3:122,953,196...123,322,392
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of PLK1 mRNA methylselenic acid affects the expression of PLK1 mRNA |
CTD |
PMID:11830524 PMID:14617803 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Pms2 |
PMS1 homolog 2, mismatch repair system component |
increases expression |
ISO |
methylselenic acid results in increased expression of PMS2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr12:10,676,818...10,701,161
Ensembl chr12:10,676,764...10,701,066
|
|
G |
Pola1 |
DNA polymerase alpha 1, catalytic subunit |
decreases expression |
ISO |
methylselenic acid results in decreased expression of POLA1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr X:58,034,617...58,348,612
Ensembl chr X:58,034,619...58,348,536
|
|
G |
Polr2h |
RNA polymerase II, I and III subunit H |
decreases expression |
ISO |
methylselenic acid results in decreased expression of POLR2H mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:80,192,017...80,197,468
Ensembl chr11:80,192,032...80,197,515 Ensembl chr10:80,192,032...80,197,515
|
|
G |
Ppfia1 |
PTPRF interacting protein alpha 1 |
affects expression |
ISO |
methylselenic acid affects the expression of PPFIA1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:199,641,277...199,718,371
Ensembl chr 1:199,641,277...199,717,277
|
|
G |
Ppil2 |
peptidylprolyl isomerase like 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PPIL2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:83,897,719...83,920,970
Ensembl chr11:83,897,764...83,922,144
|
|
G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
increases expression |
ISO |
methylselenic acid results in increased expression of PPM1B mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 6:9,646,695...9,707,471
Ensembl chr 6:9,655,765...9,707,974
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
increases expression |
ISO |
methylselenic acid results in increased expression of PPP1R15A mRNA |
CTD |
PMID:28161410 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Prkar2b |
protein kinase cAMP-dependent type II regulatory subunit beta |
increases expression |
ISO |
methylselenic acid results in increased expression of PRKAR2B mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 6:48,563,659...48,653,933
Ensembl chr 6:48,563,662...48,653,933
|
|
G |
Prkca |
protein kinase C, alpha |
increases expression |
ISO |
methylselenic acid results in increased expression of PRKCA mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
ISO |
methylselenic acid results in increased expression of PRKCB mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Prnp |
prion protein |
increases expression |
ISO |
methylselenic acid results in increased expression of PRNP mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Pten |
phosphatase and tensin homolog |
increases expression |
ISO |
methylselenic acid results in increased expression of PTEN mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptges |
prostaglandin E synthase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of PTGES mRNA |
CTD |
PMID:11830524 PMID:21669866 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Qki |
QKI, KH domain containing RNA binding |
increases expression |
ISO |
methylselenic acid results in increased expression of QKI mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:50,387,716...50,501,568
Ensembl chr 1:50,387,698...50,498,831
|
|
G |
Rab28 |
RAB28, member RAS oncogene family |
increases expression |
ISO |
methylselenic acid results in increased expression of RAB28 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr14:69,245,846...69,322,968
Ensembl chr14:69,245,854...69,322,967
|
|
G |
Rab31 |
RAB31, member RAS oncogene family |
increases expression affects expression |
ISO |
methylselenic acid results in increased expression of RAB31 mRNA methylselenic acid affects the expression of RAB31 mRNA |
CTD |
PMID:12517777 PMID:14617803 PMID:18548127 |
|
NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253
|
|
G |
Rabac1 |
Rab acceptor 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RABAC1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:80,564,029...80,567,164
Ensembl chr 1:80,564,033...80,567,163
|
|
G |
Rad9a |
RAD9 checkpoint clamp component A |
increases expression |
ISO |
methylselenic acid results in increased expression of RAD9A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:201,488,511...201,553,582
Ensembl chr 1:201,487,136...201,553,608
|
|
G |
Ralgdsl1 |
ral guanine nucleotide dissociation stimulator like 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of RGL1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:64,634,489...64,904,170
Ensembl chr13:64,635,246...64,904,191
|
|
G |
Rapgef4 |
Rap guanine nucleotide exchange factor 4 |
increases expression |
ISO |
methylselenic acid results in increased expression of RAPGEF4 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
methylselenic acid promotes the reaction [E2F1 protein binds to RB1 protein]; methylselenic acid results in decreased phosphorylation of and results in increased expression of RB1 protein |
CTD |
PMID:17847021 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rdh11 |
retinol dehydrogenase 11 |
affects expression |
ISO |
methylselenic acid affects the expression of RDH11 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:97,979,377...97,995,252
Ensembl chr 6:97,979,378...97,995,252
|
|
G |
Reep1 |
receptor accessory protein 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of REEP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338
|
|
G |
Rfc5 |
replication factor C subunit 5 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RFC5 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr12:39,207,484...39,217,041
Ensembl chr12:39,207,484...39,217,312
|
|
G |
Rgs10 |
regulator of G-protein signaling 10 |
increases expression |
ISO |
methylselenic acid results in increased expression of RGS10 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:182,946,334...182,987,729
Ensembl chr 1:182,946,336...182,987,697
|
|
G |
Rhob |
ras homolog family member B |
affects expression |
ISO |
methylselenic acid affects the expression of RHOB mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
|
|
G |
Rims3 |
regulating synaptic membrane exocytosis 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of RIMS3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:134,429,092...134,468,935
Ensembl chr 5:134,435,829...134,640,489
|
|
G |
Rnd3 |
Rho family GTPase 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of RND3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rpa2 |
replication protein A2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RPA2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:144,976,748...144,987,350
|
|
G |
Rpia |
ribose 5-phosphate isomerase A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RPIA mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:102,723,712...102,749,374
Ensembl chr 4:102,723,712...102,749,355
|
|
G |
Rpl27a |
ribosomal protein L27A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RPL27A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:163,539,732...163,542,771
|
|
G |
Rpsa |
ribosomal protein SA |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RPSA mRNA |
CTD |
PMID:11172735 |
|
NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
affects expression |
ISO |
methylselenic acid affects the expression of RRM1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
affects expression |
ISO |
methylselenic acid affects the expression of RRM2 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
|
|
G |
Rxylt1 |
ribitol xylosyltransferase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of RXYLT1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:57,770,841...57,782,695
Ensembl chr 7:57,770,842...57,782,657
|
|
G |
S100a4 |
S100 calcium-binding protein A4 |
increases expression |
ISO |
methylselenic acid results in increased expression of S100A4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
|
|
G |
Samd4a |
sterile alpha motif domain containing 4A |
increases expression |
ISO |
methylselenic acid results in increased expression of SAMD4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr15:20,135,994...20,352,131
Ensembl chr15:20,134,377...20,348,380
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
affects expression |
ISO |
methylselenic acid affects the expression of SAT1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
|
|
G |
Scd |
stearoyl-CoA desaturase |
affects expression |
ISO |
methylselenic acid affects the expression of SCD mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sdc2 |
syndecan 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of SDC2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:64,127,185...64,239,885
Ensembl chr 7:64,127,110...64,241,081
|
|
G |
Sec24d |
SEC24 homolog D, COPII coat complex component |
affects expression |
ISO |
methylselenic acid affects the expression of SEC24D mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 2:211,418,557...211,526,588
Ensembl chr 2:211,418,623...211,526,587
|
|
G |
Sema5a |
semaphorin 5A |
increases expression |
ISO |
methylselenic acid results in increased expression of SEMA5A mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
|
|
G |
Serpinb5 |
serpin family B member 5 |
increases expression affects expression |
ISO |
methylselenic acid results in increased expression of SERPINB5 mRNA methylselenic acid affects the expression of SERPINB5 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr13:22,985,557...23,005,756
Ensembl chr13:22,985,557...23,005,756
|
|
G |
Serpinb6a |
serpin family B member 6A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SERPINB6 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:30,871,468...30,989,703
Ensembl chr17:30,871,468...31,014,427
|
|
G |
Serpine2 |
serpin family E member 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of SERPINE2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Serpinf1 |
serpin family F member 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of SERPINF1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
affects expression |
ISO |
methylselenic acid affects the expression of SGK1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Sh3bgr |
SH3 domain binding glutamate-rich protein |
increases expression |
ISO |
methylselenic acid results in increased expression of SH3BGR mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:35,503,663...35,527,853
Ensembl chr11:35,503,725...35,527,853
|
|
G |
Sh3bp5 |
SH3-domain binding protein 5 |
affects expression |
ISO |
methylselenic acid affects the expression of SH3BP5 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr16:6,583,462...6,678,344
Ensembl chr16:6,583,465...6,698,975
|
|
G |
Slc14a1 |
solute carrier family 14 member 1 (Kidd blood group) |
increases expression |
ISO |
methylselenic acid results in increased expression of SLC14A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:71,565,453...71,608,807
Ensembl chr18:71,565,454...71,595,146
|
|
G |
Slc16a7 |
solute carrier family 16 member 7 |
increases expression |
ISO |
methylselenic acid results in increased expression of SLC16A7 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
|
|
G |
Slc19a1 |
solute carrier family 19 member 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SLC19A1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr20:11,584,410...11,602,429
Ensembl chr20:11,584,411...11,601,972
|
|
G |
Smad7 |
SMAD family member 7 |
increases expression |
ISO |
methylselenic acid results in increased expression of SMAD7 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SMARCA4 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:20,167,717...20,258,975
Ensembl chr 8:20,167,717...20,258,975
|
|
G |
Smarcd3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of SMARCD3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:10,548,693...10,580,334
Ensembl chr 4:10,548,751...10,580,326
|
|
G |
Smarce1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SMARCE1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr10:84,159,270...84,180,547
Ensembl chr10:84,159,275...84,179,989
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of SNAI2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Snap25 |
synaptosome associated protein 25 |
increases expression |
ISO |
methylselenic acid results in increased expression of SNAP25 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760
|
|
G |
Sncg |
synuclein, gamma |
increases expression |
ISO |
methylselenic acid results in increased expression of SNCG mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368
|
|
G |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SND1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:57,095,205...57,494,501
Ensembl chr 4:57,095,208...57,530,843
|
|
G |
Snx1 |
sorting nexin 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of SNX1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:66,630,086...66,670,418
Ensembl chr 8:66,630,086...66,670,360
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of SORBS1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [SP1 protein binds to BIRC5 promoter] |
CTD |
PMID:17876054 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Spdef |
SAM pointed domain containing ets transcription factor |
increases expression |
ISO |
methylselenic acid results in increased expression of SPDEF protein |
CTD |
PMID:18567002 |
|
NCBI chr20:5,771,440...5,785,893
Ensembl chr20:5,771,441...5,785,893
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of SPTAN1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G |
Srp19 |
signal recognition particle 19 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of SRP19 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:25,931,734...25,937,974
Ensembl chr18:25,931,589...25,938,017
|
|
G |
Ssbp2 |
single-stranded DNA binding protein 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of SSBP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:22,650,488...22,938,669
Ensembl chr 2:22,651,258...22,933,696
|
|
G |
ST7 |
suppression of tumorigenicity 7 |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of ST7 mRNA methylselenic acid affects the expression of ST7 mRNA |
CTD |
PMID:14617803 PMID:18548127 |
|
NCBI chr 4:46,041,655...46,289,745
Ensembl chr 4:46,042,236...46,289,740
|
|
G |
Stom |
stomatin |
increases expression |
ISO |
methylselenic acid results in increased expression of STOM mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
|
|
G |
Stx12 |
syntaxin 12 |
increases expression |
ISO |
methylselenic acid results in increased expression of STX12 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:145,062,978...145,092,423
Ensembl chr 5:145,063,587...145,092,377
|
|
G |
Stx1a |
syntaxin 1A |
affects expression |
ISO |
methylselenic acid affects the expression of STX1A mRNA |
CTD |
PMID:14617803 |
|
NCBI chr12:21,641,971...21,670,022
Ensembl chr12:21,641,969...21,669,930
|
|
G |
Stx2 |
syntaxin 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of STX2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:27,678,744...27,714,751
Ensembl chr12:27,689,819...27,714,751
|
|
G |
Svil |
supervillin |
increases expression |
ISO |
methylselenic acid results in increased expression of SVIL mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:52,648,502...52,844,114
Ensembl chr17:52,648,502...52,793,404
|
|
G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TACSTD2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
|
|
G |
Tarbp2 |
Tarbp2 subunit of RISC loading complex |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TARBP2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:133,649,118...133,654,306
Ensembl chr 7:133,649,090...133,654,314
|
|
G |
Tbl1x |
transducin (beta)-like 1 X-linked |
increases expression |
ISO |
methylselenic acid results in increased expression of TBL1X mRNA |
CTD |
PMID:18548127 |
|
NCBI chr X:41,574,558...41,731,117
Ensembl chr X:41,576,047...41,731,101
|
|
G |
Tbxas1 |
thromboxane A synthase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TBXAS1 mRNA |
CTD |
PMID:21669866 |
|
NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
|
|
G |
Tcn2 |
transcobalamin 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of TCN2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
methylselenic acid inhibits the reaction [afimoxifene results in increased expression of TFF1 mRNA]; methylselenic acid inhibits the reaction [Estradiol results in increased expression of TFF1 mRNA] |
CTD |
PMID:16093440 PMID:16155795 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of TGFB1 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of TGFB2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of TGFBR2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tgfbr3 |
transforming growth factor beta receptor 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of TGFBR3 mRNA |
CTD |
PMID:12517777 PMID:18548127 |
|
NCBI chr14:2,489,397...2,665,383
Ensembl chr14:2,489,397...2,663,341
|
|
G |
Tle2 |
TLE family member 2, transcriptional corepressor |
increases expression |
ISO |
methylselenic acid results in increased expression of TLE2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:8,119,049...8,135,385
Ensembl chr 7:8,119,053...8,134,306
|
|
G |
Tlr2 |
toll-like receptor 2 |
increases expression |
ISO |
methylselenic acid results in increased expression of TLR2 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
affects expression |
ISO |
methylselenic acid affects the expression of TNFAIP3 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfrsf25 |
TNF receptor superfamily member 25 |
increases expression |
ISO |
methylselenic acid results in increased expression of TNFRSF25 mRNA |
CTD |
PMID:11830524 |
|
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
|
|
G |
Top2a |
DNA topoisomerase II alpha |
affects expression |
ISO |
methylselenic acid affects the expression of TOP2A mRNA |
CTD |
PMID:14617803 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tor1aip1 |
torsin 1A interacting protein 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of TOR1AIP1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:68,196,681...68,226,121
Ensembl chr13:68,196,681...68,225,862
|
|
G |
Tpm1 |
tropomyosin 1 |
increases expression |
ISO |
methylselenic acid results in increased expression of TPM1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Trib1 |
tribbles pseudokinase 1 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TRIB1 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
|
|
G |
Trim14 |
tripartite motif-containing 14 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TRIM14 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:60,800,568...60,824,858
Ensembl chr 5:60,800,032...60,824,858
|
|
G |
Ttk |
Ttk protein kinase |
decreases expression |
ISO |
methylselenic acid results in decreased expression of TTK mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases metabolic processing |
ISO |
TXNRD1 protein results in increased metabolism of methylselenic acid |
CTD |
PMID:11782468 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Tyms |
thymidylate synthetase |
decreases expression affects expression |
ISO |
methylselenic acid results in decreased expression of TYMS mRNA methylselenic acid affects the expression of TYMS mRNA |
CTD |
PMID:12517777 PMID:14617803 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Uck2 |
uridine-cytidine kinase 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of UCK2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr13:79,380,807...79,438,121
Ensembl chr13:79,383,846...79,438,352
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
affects expression |
ISO |
methylselenic acid affects the expression of UGDH mRNA |
CTD |
PMID:14617803 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Utrn |
utrophin |
decreases expression |
ISO |
methylselenic acid results in decreased expression of UTRN mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vamp3 |
vesicle-associated membrane protein 3 |
increases expression |
ISO |
methylselenic acid results in increased expression of VAMP3 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 5:161,498,109...161,508,704
Ensembl chr 5:161,498,109...161,508,751
|
|
G |
Vdr |
vitamin D receptor |
affects expression |
ISO |
methylselenic acid affects the expression of VDR mRNA |
CTD |
PMID:16928829 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Vegfc |
vascular endothelial growth factor C |
decreases expression |
ISO |
methylselenic acid results in decreased expression of VEGFC mRNA |
CTD |
PMID:12517777 |
|
NCBI chr16:37,712,251...37,827,845
Ensembl chr16:37,712,262...37,827,848
|
|
G |
Vim |
vimentin |
increases expression |
ISO |
methylselenic acid results in increased expression of VIM mRNA |
CTD |
PMID:18548127 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wasf1 |
WASP family member 1 |
affects expression |
ISO |
methylselenic acid affects the expression of WASF1 mRNA |
CTD |
PMID:14617803 |
|
NCBI chr20:44,325,815...44,372,999
Ensembl chr20:44,325,795...44,372,996
|
|
G |
Wnt7a |
Wnt family member 7A |
decreases expression |
ISO |
methylselenic acid results in decreased expression of WNT7A mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
|
|
G |
Wsb2 |
WD repeat and SOCS box-containing 2 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of WSB2 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr12:39,217,645...39,238,634
Ensembl chr12:39,217,648...39,238,640
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases splicing |
ISO |
methylselenic acid results in increased splicing of XBP1 mRNA |
CTD |
PMID:16205645 PMID:28161410 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
decreases expression |
ISO |
methylselenic acid results in decreased expression of YWHAE mRNA |
CTD |
PMID:18548127 |
|
NCBI chr10:60,584,665...60,622,352
Ensembl chr10:60,584,652...60,671,589
|
|
G |
Zcchc24 |
zinc finger CCHC-type containing 24 |
increases expression |
ISO |
methylselenic acid results in increased expression of ZCCHC24 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr16:1,274,544...1,326,664
Ensembl chr16:1,274,548...1,326,696
|
|
G |
Zfp110 |
zinc finger protein 110 |
increases expression |
ISO |
methylselenic acid results in increased expression of ZNF274 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 1:73,445,303...73,461,112
Ensembl chr 1:73,445,336...73,461,086
|
|
G |
Zfp217 |
zinc finger protein 217 |
increases expression |
ISO |
methylselenic acid results in increased expression of ZNF217 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 3:158,890,464...158,931,148
Ensembl chr 3:158,892,265...158,913,040
|
|
G |
Zfp24 |
zinc finger protein 24 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ZNF24 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr18:15,295,687...15,307,319
Ensembl chr18:15,298,290...15,306,799
|
|
G |
Zfp267 |
zinc finger protein 267 |
increases expression |
ISO |
methylselenic acid results in increased expression of ZNF267 mRNA |
CTD |
PMID:12517777 |
|
NCBI chr 2:119,017,280...119,035,885
Ensembl chr 2:119,017,285...119,031,900
|
|
G |
Zfp458 |
zinc finger protein 458 |
decreases expression |
ISO |
methylselenic acid results in decreased expression of ZNF43 mRNA |
CTD |
PMID:18548127 |
|
NCBI chr 2:84,661,150...84,705,631
Ensembl chr 2:84,693,186...84,702,558
|
|
G |
Zfp75d |
zinc finger protein 75D |
increases expression |
ISO |
methylselenic acid results in increased expression of ZNF75D mRNA |
CTD |
PMID:12517777 |
|
NCBI chr X:134,035,116...134,053,765
Ensembl chr X:134,036,143...134,051,519
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1 |
CTD |
PMID:15897249 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 |
multiple interactions decreases expression |
EXP |
Isoflavones promotes the reaction [selenomethylselenocysteine results in decreased expression of ABCC4 mRNA] |
CTD |
PMID:19025659 |
|
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
selenomethylselenocysteine metabolite results in increased expression of APAF1 mRNA |
CTD |
PMID:25321483 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Ar |
androgen receptor |
decreases expression |
ISO EXP |
selenomethylselenocysteine results in decreased expression of AR protein selenomethylselenocysteine results in decreased expression of AR mRNA |
CTD |
PMID:16637076 PMID:19025659 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression |
ISO |
selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA |
CTD |
PMID:25321483 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Banp |
Btg3 associated nuclear protein |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of BANP mRNA |
CTD |
PMID:18514395 |
|
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
selenomethylselenocysteine results in decreased expression of BCL2 mRNA selenomethylselenocysteine results in decreased expression of BCL2 protein [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein |
CTD |
PMID:11396176 PMID:19360359 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:25321483 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bcl2l11 |
Bcl2-like 11 |
increases expression |
ISO |
selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA |
CTD |
PMID:25321483 |
|
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
decreases expression |
EXP |
selenomethylselenocysteine results in decreased expression of BMAL1 mRNA |
CTD |
PMID:19122877 |
|
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
|
|
G |
Bmf |
Bcl2 modifying factor |
multiple interactions increases expression |
ISO |
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]; HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]; selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA] selenomethylselenocysteine metabolite results in increased expression of BMF protein selenomethylselenocysteine metabolite results in increased expression of BMF mRNA; selenomethylselenocysteine metabolite results in increased expression of BMF protein |
CTD |
PMID:25321483 |
|
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression multiple interactions |
ISO |
selenomethylselenocysteine results in increased activity of CASP3 protein selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form] |
CTD |
PMID:15318939 PMID:25321483 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases expression multiple interactions |
ISO |
selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form] |
CTD |
PMID:25321483 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form |
CTD |
PMID:25321483 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form] |
CTD |
PMID:25321483 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
EXP |
selenomethylselenocysteine results in decreased expression of CCNA2 protein |
CTD |
PMID:11396176 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO EXP |
selenomethylselenocysteine results in decreased expression of CCND1 protein selenomethylselenocysteine results in decreased expression of CCND1 mRNA; selenomethylselenocysteine results in decreased expression of CCND1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of CCND1 protein |
CTD |
PMID:11396176 PMID:18855134 PMID:19276161 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
selenomethylselenocysteine results in decreased phosphorylation of and results in decreased activity of CDK2 protein |
CTD |
PMID:10656618 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
selenomethylselenocysteine metabolite results in increased expression of CDKN1A protein [Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of CDKN1A protein |
CTD |
PMID:25321483 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
EXP |
selenomethylselenocysteine results in increased expression of CDKN1B protein |
CTD |
PMID:11396176 PMID:19276161 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Ces1d |
carboxylesterase 1D |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of CES1 |
CTD |
PMID:15897249 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Chmp1a |
charged multivesicular body protein 1A |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of CHMP1A mRNA |
CTD |
PMID:18514395 |
|
NCBI chr19:51,238,153...51,246,433
Ensembl chr19:51,238,160...51,246,436
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
selenomethylselenocysteine results in decreased expression of COL1A1 mRNA; selenomethylselenocysteine results in decreased expression of COL1A1 protein |
CTD |
PMID:18514395 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
decreases expression |
ISO |
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA; selenomethylselenocysteine results in decreased expression of COL1A2 protein |
CTD |
PMID:18514395 |
|
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of COL4A5 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr X:105,118,762...105,322,699
Ensembl chr X:105,118,820...105,322,692
|
|
G |
Col6a1 |
collagen type VI alpha 1 chain |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of COL6A1 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
|
|
G |
Col7a1 |
collagen type VII alpha 1 chain |
decreases expression |
ISO |
selenomethylselenocysteine results in decreased expression of COL7A1 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
selenomethylselenocysteine results in increased expression of CRY2 mRNA |
CTD |
PMID:19122877 |
|
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions |
ISO |
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5 |
CTD |
PMID:15897249 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
increases expression |
EXP |
selenomethylselenocysteine results in increased expression of DBP mRNA |
CTD |
PMID:19122877 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of DDIT3 mRNA |
CTD |
PMID:10656618 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
decreases expression |
EXP |
selenomethylselenocysteine results in decreased expression of DHCR24 mRNA |
CTD |
PMID:19025659 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Drg1 |
developmentally regulated GTP binding protein 1 |
multiple interactions |
ISO |
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1 |
CTD |
PMID:15897249 |
|
NCBI chr14:78,103,876...78,119,976
Ensembl chr14:78,103,876...78,119,953
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter] |
CTD |
PMID:25321483 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression multiple interactions |
ISO |
selenomethylselenocysteine results in decreased expression of ESR1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of ESR1 protein |
CTD |
PMID:18855134 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
ISO |
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG |
CTD |
PMID:15897249 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of GADD45A mRNA |
CTD |
PMID:10656618 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases activity increases expression |
ISO |
selenomethylselenocysteine results in increased activity of GPX1 protein selenomethylselenocysteine results in increased expression of GPX1 mRNA; selenomethylselenocysteine results in increased expression of GPX1 protein |
CTD |
PMID:18514395 PMID:19033020 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of GPX4 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Grik1 |
glutamate ionotropic receptor kainate type subunit 1 |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of GRIK1 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645
|
|
G |
Grik3 |
glutamate ionotropic receptor kainate type subunit 3 |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of GRIK3 mRNA |
CTD |
PMID:18514395 |
|
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
|
|
G |
Hdac8 |
histone deacetylase 8 |
multiple interactions |
ISO |
HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter] |
CTD |
PMID:25321483 |
|
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
increases expression |
ISO |
selenomethylselenocysteine results in increased expression of IGF1R mRNA |
CTD |
PMID:18514395 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases phosphorylation |
EXP |
selenomethylselenocysteine results in increased phosphorylation of JUN protein |
CTD |
PMID:19276161 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klk1 |
kallikrein 1 |
decreases expression |
ISO |
selenomethylselenocysteine results in decreased expression of KLK3 protein |
CTD |
PMID:16637076 |
|
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions decreases expression |
ISO |
[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein selenomethylselenocysteine results in decreased expression of MKI67 protein |
CTD |
PMID:18855134 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Msrb1 |
methionine sulfoxide reductase B1 |
increases expression |
ISO |
selenomethylselenocysteine results in increased expre | |